Fluvastatin

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2366 publications

Involvement of Protein Kinase C Delta and Monocarboxylate Transporter 4 in the Development of Statin-Induced Cytotoxicity in a Rhabdomyosarcoma-Derived Cell Line.

Involvement of Protein Kinase C Delta and Monocarboxylate Transporter 4 in the Development of Statin-Induced Cytotoxicity in a Rhabdomyosarcoma-Derived Cell Line.

Journal: Biological & pharmaceutical bulletin

Published: September 06, 2026

Mechanisms and Predisposing Conditions for Statin-Induced New-Onset Type 2 Diabetes Mellitus: A Paradox Relative to Their Pleiotropic Metabolic Effects.

Mechanisms and Predisposing Conditions for Statin-Induced New-Onset Type 2 Diabetes Mellitus: A Paradox Relative to Their Pleiotropic Metabolic Effects.

Journal: Endocrinology, diabetes & metabolism

Published: July 07, 2026

The HMG-CoA Reductase Inhibitor Fluvastatin Promotes Th2-Skewed Immune Responses by Modulating Dendritic Cell Differentiation.

The HMG-CoA Reductase Inhibitor Fluvastatin Promotes Th2-Skewed Immune Responses by Modulating Dendritic Cell Differentiation.

Journal: Genes to cells : devoted to molecular & cellular mechanisms

Published: June 29, 2026

Solvent-Controlled Divergent Catalysis toward the Synthesis of Fluvastatin Analogs.

Solvent-Controlled Divergent Catalysis toward the Synthesis of Fluvastatin Analogs.

Journal: Organic letters

Published: June 18, 2026

A multicohort machine-learning prognostic signature reveals inflammatory immune remodeling and statin sensitivity in glioblastoma.

A multicohort machine-learning prognostic signature reveals inflammatory immune remodeling and statin sensitivity in glioblastoma.

Journal: Frontiers in oncology

Published: June 17, 2026

Drugs for hypercholesterolemia.

Drugs for hypercholesterolemia.

Journal: The Medical letter on drugs and therapeutics

Published: June 01, 2026

Comparison chart: Statins.

Comparison chart: Statins.

Journal: The Medical letter on drugs and therapeutics

Published: June 01, 2026

Transcriptomic Identification of Diagnostic Biomarkers for Alcohol-Associated Liver Cirrhosis: Integration of Population-Level Epidemiology with Multi-Cohort Transcriptomic Analysis.

Transcriptomic Identification of Diagnostic Biomarkers for Alcohol-Associated Liver Cirrhosis: Integration of Population-Level Epidemiology with Multi-Cohort Transcriptomic Analysis.

Journal: International journal of molecular sciences

Published: May 22, 2026

Drug repurposing of fluvastatin as a DP2 antagonist: an ensemble learning strategy with in vitro cellular functional validation.

Drug repurposing of fluvastatin as a DP2 antagonist: an ensemble learning strategy with in vitro cellular functional validation.

Journal: RSC medicinal chemistry

Published: May 20, 2026

QbD-guided development and in silico, in vitro, ex vivo, and in vivo dermatokinetic evaluation of a fluvastatin-loaded transferosomal hydrogel for the management of melanoma.

QbD-guided development and in silico, in vitro, ex vivo, and in vivo dermatokinetic evaluation of a fluvastatin-loaded transferosomal hydrogel for the management of melanoma.

Journal: Biomaterials advances

Published: May 09, 2026

Fluvastatin-loaded chitosan-coated transfersomes for tumor-targeted nanotheranostics: Optimization, in-vitro cytotoxicity, and in-vivo radiokinetic evaluation.

Fluvastatin-loaded chitosan-coated transfersomes for tumor-targeted nanotheranostics: Optimization, in-vitro cytotoxicity, and in-vivo radiokinetic evaluation.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: April 19, 2026

Does Ras/Rho Have Skin in the Game: The Importance of the Isoprenoid Biosynthesis Pathway in Merkel Cell Carcinoma Cell Lines.

Does Ras/Rho Have Skin in the Game: The Importance of the Isoprenoid Biosynthesis Pathway in Merkel Cell Carcinoma Cell Lines.

Journal: Cancers

Published: April 08, 2026

Showing 1-12 of 2,366

Last Updated: 09/26/2026